The chairman and also the chief executive officer (CEO) of Ontario-based YM Biosciences (YM), was preparing for the forthcoming board conference. During this conference numerous items of strategic importance would be conversed. Two possible acquisitions were being contemplated.
In order to prepare for this meeting, the chairman would have to evaluate the tactical impact of the way where the acquisitions should be ran and each of the potential acquisitions.
PUBLICATION DATE: July 13, 2008 PRODUCT #: 907N10-HCB-ENG
This is just an excerpt. This case is about STRATEGY about STRATEGY & EXECUTION